Publicaciones en colaboración con investigadores/as de Yale University (22)

2026

  1. Antiphospholipid antibodies and cardiovascular thrombosis

    Nature Reviews Cardiology

  2. Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis

    Journal of Hepatology

  3. Optimizing the Accuracy of Natural Language Processing Tools for Pulmonary Embolism Detection Through Integration with Claims Data: The PE-EHR+ Study

    Thrombosis and Haemostasis

  4. Pulmonary Embolism–Attributed Hospitalization and Mortality in the United States, 2016-2022

    Journal of the American College of Cardiology, Vol. 87, Núm. 13, pp. 1535-1538

2025

  1. Defining Organ Failures in Patients With Cirrhosis: Consensus Statements

    Gastroenterology, Vol. 169, Núm. 5, pp. 1043-1062

  2. Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future Directions

    Journal of the American College of Cardiology, Vol. 86, Núm. 14, pp. 1065-1087

  3. Isolated subsegmental pulmonary embolism identification based on international classification of diseases (ICD)-10 codes and imaging reports

    Thrombosis Research, Vol. 247

  4. Safety and effectiveness of statins in hospitalized patients with COVID-19: Systematic review and collaborative meta-analysis of randomized controlled trials

    Thrombosis Research, Vol. 255

  5. Sex differences in treatment strategies for pulmonary embolism in older adults: The SERIOUS-PE study of RIETE participants and US Medicare beneficiaries

    Vascular Medicine (United Kingdom), Vol. 30, Núm. 1, pp. 58-66

  6. Use of Present-on-Admission Indicators to Improve Accuracy of Pulmonary Embolism Identification from Electronic Health Record Data

    Seminars in Thrombosis and Hemostasis

  7. Validating International Classification of Diseases Code 10th Revision algorithms for accurate identification of pulmonary embolism

    Journal of Thrombosis and Haemostasis, Vol. 23, Núm. 2, pp. 556-564

2024

  1. Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review

    Seminars in Thrombosis and Hemostasis, Vol. 50, Núm. 6, pp. 851-865

  2. Fibrinolytic Agents in Thromboembolic Diseases: Historical Perspectives and Approved Indications

    Seminars in Thrombosis and Hemostasis, Vol. 50, Núm. 5, pp. 773-789

  3. Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease

    Nature Reviews Cardiology, Vol. 21, Núm. 8, pp. 574-592

  4. When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review

    Journal of the American College of Cardiology, Vol. 83, Núm. 3, pp. 444-465

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial

    Thrombosis and haemostasis, Vol. 123, Núm. 7, pp. 723-733

  3. Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials

    Journal of the American College of Cardiology, Vol. 81, Núm. 1, pp. 16-30

  4. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  5. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature